RecruitingISRCTN16011638
Wenyang Jieyu or placebo added to methotrexate for rheumatoid arthritis with depression
About this title
Double blind randomized controlled trial of WenyangJieyu decoction combined with methotrexate in the treatment of rheumatoid arthritis with cold dampness obstruction and depression
Read the official source — ISRCTN16011638Research studyAges 18–70China
Understand this study
Who could participate?
Listed age limits: 18 years to 70 years.
- Listed locations
- China
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Beijing Municipal Health Commission
- Sponsor type
- Unknown or unclear
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- China
- Age range
- From 18 Years to 70 Years
- Official registry ID
- ISRCTN16011638
- Official title
Show the full official title
A study of a traditional Chinese herbal formula combined with standard medication for treating a specific type of rheumatoid arthritis
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
China
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Beijing Municipal Health Commission.
Who can participate?
Listed age limits: 18 years to 70 years.
Is this study still recruiting?
The registry lists this study as recruiting.
